National Health Investors Analyst Price Targets

Wall Street analyst price targets and consensus rating for National Health Investors (NHI).

Price Target Range — 12 Quarters

Analyst Consensus — 8 Analysts

6Buy

2Hold

Consensus RatingOverweight# Analysts8Avg. Consensus PT$77Upside to Avg. PT+16.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 2, 2026	Truist Securities	Michael Lewis	PT Cut	Buy	$81→$80
Sep 1, 2026	Wells Fargo	John Kilichowski	PT Cut	Equal-Weight	$79→$78
Jun 25, 2026	Deutsche Bank	Omotayo Okusanya	PT Cut	Hold	$85→$80
Jun 15, 2026	BMO Capital	Juan Sanabria	PT Cut	Outperform	$90→$80
Jun 12, 2026	Truist Securities	Michael Lewis	PT Cut	Buy	$89→$81
Jun 1, 2026	Wells Fargo	John Kilichowski	PT Cut	Equal-Weight	$84→$79
Apr 22, 2026	Wells Fargo	John Kilichowski	PT Cut	Equal-Weight	$86→$84
Apr 22, 2026	Cantor Fitzgerald	Richard Anderson	Maintained	Overweight	$94
Apr 22, 2026	Truist Securities	Michael Lewis	PT Cut	Buy	$92→$89
Mar 27, 2026	Wells Fargo	John Kilichowski	PT Raise	Equal-Weight	$85→$86
Mar 12, 2026	Truist Securities	Michael Lewis	PT Raise	Buy	$85→$92
Dec 16, 2025	Truist Securities	Michael Lewis	PT Raise	Buy	$81→$83
Dec 4, 2025	Keybanc	Todd M. Thomas	PT Raise	Overweight	$80→$88
Nov 25, 2025	Wells Fargo	John Kilichowski	PT Raise	Equal-Weight	$80→$85
Oct 1, 2025	Cantor Fitzgerald	Richard Anderson	Initiate	Overweight	$90
Aug 27, 2025	Wells Fargo	John Kilichowski	PT Raise	Equal-Weight	$76→$80
Aug 15, 2025	Truist Securities	Michael Lewis	PT Raise	Buy	$77→$81
Jul 10, 2025	Keybanc	Craig Mailman	Upgrade	Sector Weight→Overweight	$80
Jun 9, 2025	Truist Securities	Michael Lewis	PT Raise	Hold	$76→$77
Mar 19, 2025	Truist Securities	Michael Lewis	PT Raise	Hold	$70→$76

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Truist Securities Maintains Buy on National Health Investors, Lowers Price Target to $80

Truist Securities analyst Michael Lewis maintains National Health Investors (NYSE:NHI) with a Buy and lowers the price target from $81 to $80.

Benzinga Newsdesk

PRO
Wells Fargo Maintains Equal-Weight on National Health Investors, Lowers Price Target to $78

Wells Fargo analyst John Kilichowski maintains National Health Investors (NYSE:NHI) with a Equal-Weight and lowers the price target from $79 to $78.

Benzinga Newsdesk

PRO
Deutsche Bank Maintains Hold on National Health Investors, Lowers Price Target to $80

Deutsche Bank analyst Omotayo Okusanya maintains National Health Investors (NYSE:NHI) with a Hold and lowers the price target from $85 to $80.

Benzinga Newsdesk

PRO
BMO Capital Maintains Outperform on National Health Investors, Lowers Price Target to $80

BMO Capital analyst Juan Sanabria maintains National Health Investors (NYSE:NHI) with a Outperform and lowers the price target from $90 to $80.

Benzinga Newsdesk

PRO
Truist Securities Maintains Buy on National Health Investors, Lowers Price Target to $81

Truist Securities analyst Michael Lewis maintains National Health Investors (NYSE:NHI) with a Buy and lowers the price target from $89 to $81.

Benzinga Newsdesk

PRO
Wells Fargo Maintains Equal-Weight on National Health Investors, Lowers Price Target to $79

Wells Fargo analyst John Kilichowski maintains National Health Investors (NYSE:NHI) with a Equal-Weight and lowers the price target from $84 to $79.

Benzinga Newsdesk

National Health Investors Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

National Health Investors Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Truist Securities Maintains Buy on National Health Investors, Lowers Price Target to $80

PRO
Wells Fargo Maintains Equal-Weight on National Health Investors, Lowers Price Target to $78

PRO
Deutsche Bank Maintains Hold on National Health Investors, Lowers Price Target to $80

PRO
BMO Capital Maintains Outperform on National Health Investors, Lowers Price Target to $80

PRO
Truist Securities Maintains Buy on National Health Investors, Lowers Price Target to $81

PRO
Wells Fargo Maintains Equal-Weight on National Health Investors, Lowers Price Target to $79

People Also Watch

People Also Watch

National Health Investors Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

National Health Investors Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROTruist Securities Maintains Buy on National Health Investors, Lowers Price Target to $80

PROWells Fargo Maintains Equal-Weight on National Health Investors, Lowers Price Target to $78

PRODeutsche Bank Maintains Hold on National Health Investors, Lowers Price Target to $80

PROBMO Capital Maintains Outperform on National Health Investors, Lowers Price Target to $80

PROTruist Securities Maintains Buy on National Health Investors, Lowers Price Target to $81

PROWells Fargo Maintains Equal-Weight on National Health Investors, Lowers Price Target to $79

People Also Watch

People Also Watch

PRO
Truist Securities Maintains Buy on National Health Investors, Lowers Price Target to $80

PRO
Wells Fargo Maintains Equal-Weight on National Health Investors, Lowers Price Target to $78

PRO
Deutsche Bank Maintains Hold on National Health Investors, Lowers Price Target to $80

PRO
BMO Capital Maintains Outperform on National Health Investors, Lowers Price Target to $80

PRO
Truist Securities Maintains Buy on National Health Investors, Lowers Price Target to $81

PRO
Wells Fargo Maintains Equal-Weight on National Health Investors, Lowers Price Target to $79